4//SEC Filing
Patel Anish 4
Accession 0001415889-25-010474
CIK 0001672619other
Filed
Apr 8, 8:00 PM ET
Accepted
Apr 9, 4:25 PM ET
Size
9.7 KB
Accession
0001415889-25-010474
Insider Transaction Report
Form 4
Patel Anish
CHIEF OPERATING OFFICER
Transactions
- Sale
Common Stock
2025-04-07$17.81/sh−3,756$66,889→ 319,554 total(indirect: See footnote) - Sale
Common Stock
2025-04-07$19.27/sh−148$2,852→ 316,643 total(indirect: See footnote) - Sale
Common Stock
2025-04-07$18.29/sh−2,763$50,527→ 316,791 total(indirect: See footnote)
Footnotes (5)
- [F1]The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on September 30, 2024 by the Reporting Person and by The Patel / Dong Family Trust Dated August 24, 2017, for which the Reporting Person serves as trustee (the "Patel / Dong Family Trust").
- [F2]This transaction was executed in multiple trades at prices ranging from $16.985 to $17.975. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price.
- [F3]The shares are held by The Patel / Dong Family Trust.
- [F4]This transaction was executed in multiple trades at prices ranging from $17.995 to $18.98. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price.
- [F5]This transaction was executed in multiple trades at prices ranging from $18.995 to $19.4361. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price.
Documents
Issuer
Enliven Therapeutics, Inc.
CIK 0001672619
Entity typeother
Related Parties
1- filerCIK 0001967163
Filing Metadata
- Form type
- 4
- Filed
- Apr 8, 8:00 PM ET
- Accepted
- Apr 9, 4:25 PM ET
- Size
- 9.7 KB